unknown
Stage
1
Investors
About
Informuta develops a predictive platform that uses genomics and AI to forecast antimicrobial resistance, enabling clinicians to select effective treatments and prevent resistance before it arises.
Explore Informuta's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.